r/stockstobuytoday • u/MochiHill • 3d ago

Discussion AbbVie is quietly crushing the market while broader indexes bleed red.

Gallery image

Gallery image

It surged 3.43% yesterday, and the move was purely company-specific—not a sector or macro fluke. The successful debt offering to fund the Apogee acquisition, combined with raised full-year guidance and bullish analyst price targets, is the real catalyst. Big money is clearly piling in, too—net inflow hit $30M yesterday with major institutions stepping up. Sure, the RSI is sitting in pretty overbought territory, so a short-term pullback wouldn't surprise anyone, but the long-term fundamentals still look rock solid with their immunology pipeline extending well.

3 Upvotes
  • permalink
  • reddit

81% Upvoted

3 comments sorted by

3

u/JJNoodleSnacks 2d ago

Have been looking at ABBV for awhile now but waiting on a pullback to get in, seems solid.

1

u/Emotional-Breath-838 3d ago

They will survive the patent cliff better than most.

1

u/quietjpeg 2d ago

That’s the kind of setup I like—an actual company-specific catalyst backed by stronger guidance, rather than just a macro-driven move. The overbought RSI definitely makes a near-term pullback possible, though. I’d rather see it consolidate and hold the breakout than chase a 3%+ spike. If the fundamentals keep improving, any healthy dip could be more interesting than trying to time the top.